US Stock MarketDetailed Quotes

ORKA Oruka Therapeutics

Watchlist
  • 10.350
  • -0.590-5.39%
Trading Mar 11 10:44 ET
387.51MMarket Cap-27.24P/E (TTM)

About Oruka Therapeutics Company

Oruka Therapeutics, Inc. is a biotechnology company, which focuses on developing novel monoclonal antibody therapeutics for PsO and other I&I indications. Its pipeline includes ORKA-001 and ORKA-002. The company is headquartered in Menlo Park, CA.

Company Profile

SymbolORKA
Company NameOruka Therapeutics
Listing DateAug 8, 1997
CEODr. Lawrence Otto Klein, PhD
MarketNASDAQ
Employees36
Fiscal Year Ends12-31
Address855 Oak Grove Avenue,Suite 100
CityMenlo Park
ProvinceCalifornia
CountryUnited States of America
Zip Code94025
Phone1-650-606-7910

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Lawrence Otto Klein, PhD
  • Director, President and Chief Executive Officer
  • 520.91K
  • Dr. Joana Goncalves, M.D.
  • Chief Medical Officer
  • 317.99K
  • Arjun Agarwal
  • Senior Vice President, Finance and Treasurer
  • --
  • Dr. Samarth Kulkarni, PhD
  • Chairman of the Board
  • 27.74K
  • Dr. Cameron Turtle, D.Phil.
  • Independent Director
  • --
  • Dr. Carl Dambkowski, M.D.
  • Independent Director
  • 16.27K
  • Kristine M. Ball
  • Independent Director
  • 20.55K
  • Peter Harwin
  • Independent Director
  • 19.18K
  • Paul T. Quinlan PhD
  • General Counsel and Corporate Secretary
  • 310.45K

Trending Stocks

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Unlock Now
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
Big Tech’s earnings season in full swing! Nvidia is the only one left
On Thursday, $Amazon (AMZN.US)$ stock fell after the firm reported Q4 adjusted earnings of $1.86/share, vs estimates of $1.50/share, on reve Show More